NPI 1225165111: Open Payments
NPI 1225165111. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 24 payments from 3 companies in 2025. Trend: 2023 $1,773 · 2024 $1,890 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $308 |
| Daiichi Sankyo Inc. | 4 | $88 |
| ABBVIE INC. | 3 | $69 |
Products named: XIFAXAN, INJECTAFER, RINVOQ.
